Trusted Sources

BUPRENORPHINE Questions ? Need a second opinion? Ask Our Health Experts!

Type your question here

 letters left

BUPRENORPHINE Safety Reports

Total BUPRENORPHINE reports: 306. BUPRENORPHINE FDA safety alerts: 2003 . Reported deaths: 48    Reported hospitalizations: 152. Read More Here.

< Previous  Showing 101-150 of 306 Next >

Consumer or non-health professional from FRANCE reported BUPRENORPHINE problem on Feb 24, 2006. Male patient, 31 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: arthritis, arthropathy, injection site reaction, klebsiella infection, peripheral ischaemia. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.

BUPRENORPHINE problem was reported by a Physician from GREECE on Feb 09, 2006. Male patient, 56 years of age, weighting 264.6 lb, was diagnosed with hypertension, angiopathy and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: electrocardiogram q waves. BUPRENORPHINE dosage: unknown. During the same period patient was treated with AMLODIPINE BESYLATE, ASPIRIN, ALLOPURINOL, DIOSMIN, CARVEDILOL. Patient recovered.

Health Professional from FRANCE reported BUPRENORPHINE problem on Feb 09, 2006. Male patient, 57 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: loss of consciousness, overdose, pneumonia aspiration. BUPRENORPHINE dosage: unknown. During the same period patient was treated with LORZAAR PLUS, URAPIDIL, HEXAQUINE, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

BUPRENORPHINE problem was reported by a Physician from FINLAND on Feb 07, 2006. Female patient, 25 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: abortion induced, dilatation ventricular, ductus arteriosus premature closure, pulmonary hypertension, ventricular hypoplasia. BUPRENORPHINE dosage: unknown. During the same period patient was treated with DEXTROAMPHETAMINE, DIAZEPAM, MIDAZOLAM, LOFEXIDINE. Patient died.

Health Professional from FRANCE reported BUPRENORPHINE problem on Feb 22, 2006. Male patient, 41 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: calculus urethral, calculus urinary, renal pain. BUPRENORPHINE dosage: unknown. During the same period patient was treated with BACTRIM, FOLIC ACID, RITONAVIR, COMBIVIR, FOSAMPRENAVIR. Patient was hospitalized. Patient recovered.

BUPRENORPHINE problem was reported by a Health Professional from FRANCE on Nov 17, 2004. Female patient, 34 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: abscess, anaemia, headache, klebsiella infection, nausea, sepsis, staphylococcal infection, waldenstrom's macroglobulinaemia. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported BUPRENORPHINE problem on Feb 10, 2006. Male patient, 39 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: agitation, cardiac murmur, dysphonia, dyspnoea exertional, pneumonia. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.

BUPRENORPHINE problem was reported by a Health Professional from FRANCE on Oct 19, 2005. Female patient, 26 years of age, weighting 145.5 lb, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: depression. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported BUPRENORPHINE problem on Feb 13, 2006. Female patient, 24 years of age, weighting 110.2 lb, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: arthritis bacterial, hypergammaglobulinaemia, intervertebral discitis, methicillin-resistant staphylococcal aureus test positive, normochromic normocytic anaemia. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.

BUPRENORPHINE problem was reported by a Health Professional from FRANCE on Feb 10, 2006. Female patient, weighting 21.61 lb, was diagnosed with accidental exposure and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: accidental exposure, blood glucose decreased, laryngeal dyspnoea, miosis, pyrexia, somnolence, tachycardia, urinary retention. BUPRENORPHINE dosage: unknown. During the same period patient was treated with OXYBUTYNIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported BUPRENORPHINE problem on Feb 10, 2006. Female patient, 32 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: anaemia, anorexia, aortic aneurysm, asthenia, lymphadenitis, platelet count increased, staphylococcal sepsis. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.

BUPRENORPHINE problem was reported by a Physician from FRANCE on Feb 15, 2006. Male patient, 25 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: cyanosis, injection site pain, mobility decreased, necrosis, rash erythematous, rash pustular, swelling. BUPRENORPHINE dosage: unknown. Patient recovered.

Physician from SWEDEN reported BUPRENORPHINE problem on Jan 03, 2006. Female patient was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: restlessness, speech disorder developmental. BUPRENORPHINE dosage: unknown. Patient recovered.

BUPRENORPHINE problem was reported by a Physician from SWEDEN on Jan 03, 2006. Female patient was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: developmental delay. BUPRENORPHINE dosage: unknown. Patient recovered.

Health Professional from FRANCE reported BUPRENORPHINE problem on Feb 22, 2006. Male patient, 41 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: calculus urethral, calculus urinary, renal pain. BUPRENORPHINE dosage: unknown. During the same period patient was treated with BACTRIM, FOLIC ACID, RITONAVIR, COMBIVIR, FOSAMPRENAVIR, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

BUPRENORPHINE problem was reported by a Physician from SWEDEN on Jan 03, 2006. Male patient was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: restlessness, speech disorder developmental. BUPRENORPHINE dosage: unknown. Patient recovered.

Physician from SWEDEN reported BUPRENORPHINE problem on Jan 03, 2006. Male patient was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: developmental delay. BUPRENORPHINE dosage: unknown. Patient recovered.

BUPRENORPHINE problem was reported by a Physician from SWEDEN on Jan 03, 2006. Male patient was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: restlessness, speech disorder developmental. BUPRENORPHINE dosage: unknown. Patient recovered.

Health Professional from FRANCE reported BUPRENORPHINE problem on Nov 17, 2004. Female patient, 25 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: anaemia, cardiac tamponade, endocarditis staphylococcal, shock, thrombocytopenia. BUPRENORPHINE dosage: unknown. During the same period patient was treated with HEROIN. Patient was hospitalized. Patient recovered.

BUPRENORPHINE problem was reported by a Health Professional from FRANCE on Feb 10, 2006. Female patient, 32 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: anorexia, aortic aneurysm, asthenia, lymphadenitis, platelet count increased, staphylococcal sepsis, weight decreased. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BUPRENORPHINE problem on Feb 27, 2006. Female patient, weighting 110.1 lb, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, chest discomfort, diarrhoea, dyspnoea, hyperhidrosis, insomnia, nausea, urinary retention. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.

BUPRENORPHINE problem was reported by a Health Professional from UNITED KINGDOM on Mar 01, 2006. Female patient was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: premature labour. BUPRENORPHINE dosage: unknown. Patient recovered.

Physician from SWEDEN reported BUPRENORPHINE problem on Jan 03, 2006. Male patient was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: developmental delay. BUPRENORPHINE dosage: unknown. Patient recovered.

BUPRENORPHINE problem was reported by a Physician from GREECE on Feb 09, 2006. Male patient, 56 years of age, weighting 264.6 lb, was diagnosed with hypertension, angiopathy and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: silent myocardial infarction. BUPRENORPHINE dosage: unknown. During the same period patient was treated with AMLODIPINE BESYLATE, ASPIRIN, ALLOPURINOL, DIOSMIN, CARVEDILOL. Patient recovered.

Health Professional from UNITED KINGDOM reported BUPRENORPHINE problem on Apr 21, 2005. Female patient was diagnosed with detoxification and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: premature separation of placenta. BUPRENORPHINE dosage: unknown. Patient recovered.

BUPRENORPHINE problem was reported by a Health Professional from UNITED KINGDOM on Feb 17, 2006. Male patient was diagnosed with diabetes mellitus and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: headache, rash macular. BUPRENORPHINE dosage: unknown. During the same period patient was treated with INSULIN. Patient recovered.

Physician from SINGAPORE reported BUPRENORPHINE problem on Feb 21, 2006. Male patient, 32 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: asthenia, difficulty in walking, pain in extremity, peroneal nerve palsy, swelling, tenderness. BUPRENORPHINE dosage: CRUSHED 4 TABLETS TO FORM A 2 ML SOLUTION IN BOILER WATER. Patient was hospitalized. Patient recovered.

BUPRENORPHINE problem was reported by a Health Professional from FRANCE on Mar 06, 2006. Male patient, 33 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased, hepatitis, jaundice. BUPRENORPHINE dosage: unknown. During the same period patient was treated with FLUOXETINE, SULPIRIDE, CLONAZEPAM. Patient recovered.

Health Professional from FRANCE reported BUPRENORPHINE problem on Feb 24, 2006. Male patient, 21 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: hepatitis c, pleural effusion, pneumonia. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.

BUPRENORPHINE problem was reported by a Health Professional from FRANCE on Mar 06, 2006. Male patient, 25 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased, hepatitis. BUPRENORPHINE dosage: unknown. During the same period patient was treated with LORAZEPAM, CLORAZEPATE DIPOTASSIUM, BROMAZEPAM. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported BUPRENORPHINE problem on Oct 19, 2005. Female patient, 26 years of age, weighting 145.5 lb, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: dependence, depression. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.

BUPRENORPHINE problem was reported by a Health Professional from UNITED KINGDOM on Mar 01, 2006. Female patient was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: premature baby. BUPRENORPHINE dosage: unknown. Patient recovered.

Health Professional from UNITED KINGDOM reported BUPRENORPHINE problem on Mar 01, 2006. Female patient was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: premature baby. BUPRENORPHINE dosage: unknown. Patient recovered.

BUPRENORPHINE problem was reported by a Health Professional from UNITED KINGDOM on Apr 21, 2005. Female patient was diagnosed with detoxification and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: premature separation of placenta. BUPRENORPHINE dosage: unknown. Patient recovered.

Physician from FRANCE reported BUPRENORPHINE problem on Mar 03, 2006. Male patient, weighting 4.63 lb, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: coma, convulsion neonatal, growth retardation, hypotonia neonatal, tremor neonatal. BUPRENORPHINE dosage: unknown. During the same period patient was treated with DOSULEPIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

BUPRENORPHINE problem was reported by a Consumer or non-health professional from FRANCE on Feb 24, 2006. Male patient, 31 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: arthritis, arthropathy, injection site reaction, klebsiella infection, mitral valve disease, peripheral ischaemia. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported BUPRENORPHINE problem on Feb 10, 2006. Female patient, weighting 21.61 lb, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: accidental exposure, blood glucose decreased, laryngeal dyspnoea, miosis, pyrexia, somnolence, tachycardia, urinary retention. BUPRENORPHINE dosage: unknown. During the same period patient was treated with OXYBUTYNIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

BUPRENORPHINE problem was reported by a Physician from JAPAN on July 25, 2005. Female patient was diagnosed with analgesic effect, gastric ulcer, hypertension, arteriosclerosis and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: delirium. BUPRENORPHINE dosage: unknown. During the same period patient was treated with LANSOPRAZOLE, CANDESARTAN CILEXETIL, FUROSEMIDE, RED BLOOD CELLS, RED BLOOD CELLS, RED BLOOD CELLS, ALPROSTADIL. Patient was hospitalized. Patient recovered.

Physician from ITALY reported BUPRENORPHINE problem on Mar 17, 2006. Male patient, 24 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: hepatitis cholestatic, hepatitis toxic, herpes virus infection. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.

BUPRENORPHINE problem was reported by a Health Professional from FRANCE on Jan 09, 2006. Female patient, 28 years of age, weighting 88.18 lb, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: anorexia, cardiac valve vegetation, endocarditis staphylococcal, inflammation, pulmonary sepsis, tricuspid valve incompetence. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported BUPRENORPHINE problem on Mar 16, 2006. Female patient, 75 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: psychotic disorder. BUPRENORPHINE dosage: unknown. Patient recovered.

BUPRENORPHINE problem was reported by a Physician from UNITED STATES on Mar 16, 2006. Female patient, 75 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: psychotic disorder. BUPRENORPHINE dosage: unknown. Patient recovered.

Physician from UNITED STATES reported BUPRENORPHINE problem on Mar 16, 2006. Female patient, 75 years of age, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: psychotic disorder. BUPRENORPHINE dosage: unknown. Patient recovered.

BUPRENORPHINE problem was reported by a Health Professional from FRANCE on Jan 09, 2006. Female patient, 28 years of age, weighting 88.18 lb, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: anorexia, endocarditis staphylococcal, inflammation, pulmonary sepsis, tricuspid valve incompetence. BUPRENORPHINE dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported BUPRENORPHINE problem on Feb 22, 2006. Male patient, 41 years of age, was diagnosed with hiv infection and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: calculus urethral, calculus urinary, pneumothorax, pulmonary necrosis, renal pain, septic shock. BUPRENORPHINE dosage: unknown. During the same period patient was treated with BACTRIM, FOLIC ACID, RITONAVIR, COMBIVIR, FOSAMPRENAVIR. Patient was hospitalized. Patient recovered.

BUPRENORPHINE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 09, 2006. Male patient, weighting 173.0 lb, was diagnosed with pain and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: somnolence. BUPRENORPHINE dosage: 4ML/SQ/DAY. During the same period patient was treated with MAGNESIUM SULPHATE, FISH OIL, VERAPAMIL. Patient recovered.

Health Professional from FRANCE reported BUPRENORPHINE problem on Mar 27, 2006. Male patient, 35 years of age, was diagnosed with sleep disorder and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: accidental needle stick. BUPRENORPHINE dosage: unknown. During the same period patient was treated with FLUNITRAZEPAM. Patient was hospitalized. Patient recovered.

BUPRENORPHINE problem was reported by a Health Professional from FRANCE on Feb 10, 2006. Female patient, weighting 21.61 lb, was diagnosed with accidental exposure and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: accidental exposure, blood glucose decreased, dyspnoea, laryngeal dyspnoea, miosis, pyrexia, respiratory depression, somnolence. BUPRENORPHINE dosage: unknown. During the same period patient was treated with OXYBUTYNIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported BUPRENORPHINE problem on Mar 27, 2006. Female patient, 31 years of age, was diagnosed with sleep disorder and was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, skin graft, skin ulcer. BUPRENORPHINE dosage: unknown. During the same period patient was treated with FLUNITRAZEPAM, ALIMEMAZINE TARTRATE, DIAZEPAM, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.

BUPRENORPHINE problem was reported by a Health Professional from UNITED KINGDOM on Mar 27, 2006. Male patient, 26 years of age, weighting 154.3 lb, was treated with BUPRENORPHINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, biliary colic, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, overdose. BUPRENORPHINE dosage: 32 X 8MG TABLETS, 17 X 2MG - TOTAL 290MG - SWALLOWED WRAPPED IN CLINGFILM. During the same period patient was treated with METHADONE. Patient was hospitalized. Patient recovered.

< Previous  Showing 101-150 of 306 Next >